HRD gained prominence with the discovery that mutations in the breast cancer genes BRCA1 (Breast Cancer Gene 1) or BRCA2 (Breast Cancer Gene 2) impair HRR [3,4]. This evidence concerns the gene BRCA2 and breast cancer.